Edge Asset Management’s GSK GSK Stock Holding History

Edge Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$588K	Hold	11,166	–	–	﹤0.01%	260
2016 Q4	$538K	Hold	11,166	–	–	﹤0.01%	265
2016 Q3	$602K	Hold	11,166	–	–	0.01%	259
2016 Q2	$605K	Sell	11,166 -57,503	-84%	-$3.03M	0.01%	259
2016 Q1	$3.48M	Sell	68,669 -171,897	-71%	-$8.56M	0.03%	243
2015 Q4	$12.1M	Sell	240,566 -50,712	-17%	-$2.58M	0.12%	198
2015 Q3	$14M	Sell	291,278 -119,737	-29%	-$6.23M	0.14%	178
2015 Q2	$21.4M	Sell	411,015 -189,955	-32%	-$10.7M	0.19%	144
2015 Q1	$34.7M	Sell	600,970 -220,793	-27%	-$12.7M	0.3%	113
2014 Q4	$43.9M	Sell	821,763 -394,015	-32%	-$22M	0.42%	75
2014 Q3	$69.9M	Buy	1,215,778 +62,800	+5%	+$3.85M	0.7%	49
2014 Q2	$77.1M	Sell	1,152,978 -3,752	-0.3%	-$254K	0.77%	45
2014 Q1	$77.3M	Buy	1,156,730 +18,750	+2%	+$1.27M	0.82%	40
2013 Q4	$75.9M	Sell	1,137,980 -1,168,030	-51%	-$75.7M	0.83%	41
2013 Q3	$144M	Buy	2,306,010 +1,149,130	+99%	+$74M	0.88%	38
2013 Q2	$72.3M	Buy	+1,156,880	New	+$73.4M	0.91%	37

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Edge Asset Management's GSK Position: Q1 2017 in Review

Edge Asset Management held its GSK (GSK) position steady in Q1 2017 at 11,166 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #260.

Edge Asset Management first reported a position in GSK in Q2 2013 and has held it in 16 quarters since. The position peaked at $144M in Q3 2013. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Edge Asset Management held 11,166 shares of GSK worth $588K as of Q1 2017.
Edge Asset Management left its GSK share count unchanged in Q1 2017.
GSK made up ﹤0.01% of Edge Asset Management's portfolio in Q1 2017, its #260 holding.
Edge Asset Management first reported a position in GSK in Q2 2013 and has held it in 16 quarters since.
Edge Asset Management's GSK position peaked at $144M in Q3 2013.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.